Oxford Nanopore Technologies (ONT) Competitors GBX 144.60 -0.10 (-0.07%) As of 08:38 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ONT vs. BTG, ABC, GNS, ERGO, SLN, PRTC, OXB, HZD, FARN, and VRPShould you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include BTG (BTG), Abcam (ABC), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), and Verona Pharma plc (VRP.L) (VRP). These companies are all part of the "biotechnology" industry. Oxford Nanopore Technologies vs. Its Competitors BTG Abcam Genus Ergomed Silence Therapeutics PureTech Health Oxford Biomedica Horizon Discovery Group plc (HZD.L) Faron Pharmaceuticals Oy Verona Pharma plc (VRP.L) BTG (LON:BTG) and Oxford Nanopore Technologies (LON:ONT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings. Is BTG or ONT more profitable? BTG has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. BTG's return on equity of 0.00% beat Oxford Nanopore Technologies' return on equity.Company Net Margins Return on Equity Return on Assets BTGN/A N/A N/A Oxford Nanopore Technologies -94.82%-26.02%-14.42% Which has preferable valuation & earnings, BTG or ONT? BTG has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBTG£914.10M0.00N/A£28.50N/AOxford Nanopore Technologies£184.78M7.43-£175.21M-£18.58-7.78 Does the media prefer BTG or ONT? In the previous week, BTG had 8 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 8 mentions for BTG and 0 mentions for Oxford Nanopore Technologies. BTG's average media sentiment score of 0.01 beat Oxford Nanopore Technologies' score of 0.00 indicating that BTG is being referred to more favorably in the media. Company Overall Sentiment BTG Neutral Oxford Nanopore Technologies Neutral Do analysts recommend BTG or ONT? Oxford Nanopore Technologies has a consensus price target of GBX 220, suggesting a potential upside of 52.14%. Given Oxford Nanopore Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Oxford Nanopore Technologies is more favorable than BTG.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BTG 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Oxford Nanopore Technologies 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of BTG or ONT? 38.4% of Oxford Nanopore Technologies shares are owned by institutional investors. 32.6% of Oxford Nanopore Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryBTG beats Oxford Nanopore Technologies on 8 of the 13 factors compared between the two stocks. Get Oxford Nanopore Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ONT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONT vs. The Competition Export to ExcelMetricOxford Nanopore TechnologiesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.37B£129.10M£5.50B£2.97BDividend YieldN/A3.74%5.25%5.02%P/E Ratio-7.783.4026.97151.95Price / Sales7.434,210.11426.02249,943.19Price / Cash4.0413.1936.8227.97Price / Book2.1542.427.984.56Net Income-£175.21M-£92.79M£3.16B£5.90B7 Day Performance2.43%8.82%2.36%1.78%1 Month Performance17.41%2.63%2.15%4.51%1 Year Performance43.17%182.01%33.78%80.51% Oxford Nanopore Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONTOxford Nanopore TechnologiesN/AGBX 144.60-0.1%GBX 220+52.1%+38.6%£1.37B£184.78M-7.781,281BTGBTGN/AN/AN/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeGNSGenus0.6827 of 5 starsGBX 2,130flatGBX 2,150+0.9%+23.3%£1.39B£666.67M176.56480News CoverageERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health3.0574 of 5 starsGBX 126.22-0.9%GBX 455+260.5%-29.4%£379.13M£521.32K-5.18300News CoveragePositive NewsOXBOxford Biomedica2.2927 of 5 starsGBX 337.36+0.7%GBX 380+12.6%+3.8%£358.62M£98.31M-2.51891Positive NewsHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416FARNFaron Pharmaceuticals OyN/AGBX 217+0.9%N/A+124.9%£291.33MN/A-5.8034News CoverageVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap Up Related Companies and Tools Related Companies BTG Alternatives Abcam Alternatives Genus Alternatives Ergomed Alternatives Silence Therapeutics Alternatives PureTech Health Alternatives Oxford Biomedica Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Faron Pharmaceuticals Oy Alternatives Verona Pharma plc (VRP.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ONT) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Nanopore Technologies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Nanopore Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONT Stock Alerts